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A 64-year-old male patient complained of a one-month history of bloody sputum. A polypoid tumor was
almost obstructing the oriﬁce of the subsegmental bronchus (B8b) of the anterior basal segment of the
right lower lobe on bronchoscopy. Biopsy specimens of the tumor surface yielded a diagnosis of
undifferentiated carcinoma. Clinical staging was T1aN0M0, stage IA. Surgical resection that comprised
a right upper lobectomy with systematic mediastinal and hilar lymph node dissection was performed.
Histopathologically, the tumor specimen was compatible with large-cell neuroendocrine carcinoma
(LCNEC) of the subsegmental bronchus. Pathological staging was T1aN0M0, stage IA. To our knowledge,
few cases of central-type LCNEC have been reported in the English literature, and ours is the ﬁrst report
of roentgenological occult LCNEC.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Large-cell neuroendocrine carcinoma (LCNEC) of the lung was
proposed in 1991 by Travis et al.1 This tumor was categorized in
the spectrum of pulmonary neuroendocrine tumors such as
typical carcinoid tumors, atypical carcinoid tumors, LCNEC, and
small cell carcinoma. The revised WHO International Histological
Classiﬁcation of lung tumors considers LCNEC as a subtype of
large-cell carcinoma.2 The present case involved LCNEC, as deter-
mined by the presence of nuclei with remarkable atypia and
morphology.
LCNEC is found in 2.93 to 3.1%4 of resected specimens of
primary lung cancer. It is a rare tumor and has a tendency to affect
individuals with a smoking history1,5 and males.4 LCNEC typically
occurs in the peripheral lung ﬁeld, and only two individual cases
of central-type LCNEC have been reported in the English litera-
ture.5,6 Thus, we present a long-term survival case of central-type
LCNEC, which represents the ﬁrst report of roentgenological
occult LCNEC.: þ81 27 243 3380.
iyoshihara).
-NC-ND license.2. Case
A 64-year-old male patient was referred for further examination
because of a 1-month history of bloody sputum. The patient had no
relevant medical history, but had smoked 1.5 packs of cigarettes
daily from 20 to 25 years of age. His physical examination, routine
laboratory test results, sputum cytology, and tumor markers were
normal (CEA 2.6 ng/ml, NSE 3.8 ng/ml, Pro-GRP 19.7 ng/ml, and
CYFRA 0.7 ng/ml).
Chest roentgenography and computed tomography (CT) showed
no remarkable ﬁndings. On endoscopy, a polypoid tumor was found
obstructing the oriﬁce of the subsegmental bronchus (B8b) of the
anterior basal segment of the right lower lobe (Fig. 1a). Biopsy
specimens of the tumor surface yielded a diagnosis of undifferen-
tiated carcinoma. 18F-ﬂuorodeoxyglucose positron emission
tomography (FDG-PET)/CT imaging and brain magnetic resonance
imaging were negative for distant and lymph node metastasis.
Clinical staging was T1aN0M0, stage IA. Surgical resection that
comprised a right upper lobectomy with systematic mediastinal
and hilar lymph node dissection was performed.
On gross examination, there was a 1.0  0.9  0.8-cm white
tumor originating from the bronchial mucosa of B8b (Fig. 1b). The
tumor did not invade the pulmonary parenchyma (Fig. 1c). On
histological examination, the tumor showed solid growth patterns
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necrosis was also seen (Fig. 2c), and at a higher magniﬁcation, the
neoplastic cells showed remarkably atypical and pleomorphic
nuclei and ﬁnely granular chromatin (Fig. 2d). Amitotic rate of up to
134 mitoses per 10 high-power ﬁelds was observed. In immuno-
histochemical studies, the neoplastic cells were found to be positive
for synaptophysin (Fig. 3a), chromogranin A (Fig. 3b), and CD56
(Fig. 3c). Based on the histopathological and immunohistochemical
features, typical carcinoid and non-small-cell lung carcinoma with
neuroendocrine features were ruled out. These ﬁndings were
compatible with LCNEC from the subsegmental bronchus,
T1aN0M0, stage IA.
The patient’s postoperative course was uneventful, and he was
discharged on postoperative day ﬁve. The patient was doing well
without recurrence 70 months after the operation and is being
followed as an outpatient.3. Discussion
Reports of central-type LCNEC are very rare. The difference
between central- and peripheral-type LCNEC remains unknown. As
described above, LCNEC is positioned within the spectrum of
neuroendocrine tumors. Interestingly, however, the clinical
features in our case, such as central-type, smoker, and male, are
similar to those of squamous cell carcinoma, most cases of which
have a smoking history and male tendency and are located in the
segmental bronchi or centrally in approximately two-thirds of
cases. These features are more characteristic of squamous cell
carcinoma than of LCNEC.
We found only two individual reports on roentgenological
occult large-cell neuroendocrine carcinoma in the English litera-
ture. Megyesi et al.6 reported a 58-year-old patient with LCNEC
involving an endobronchial location, which was removed by right
middle lobectomy. The authors suggested some similarities to
atypical carcinoid, such as endobronchial growth, non-smoker,
good prognosis (36-month survival), and carcinoid-like
morphology. However, the presence of up to 20 mitoses per 10
high-power ﬁelds allowed for a diagnosis of LCNEC. They then
proposed a redeﬁnition of the histologic criteria to allow a higher
mitotic rate for classiﬁcation as an atypical carcinoid. Tokuyasu
et al.7 admitted the similarity to Megyesi’s case,6 but stated that
there were differences from an atypical carcinoid tumor because of
the high mitotic rate and morphology and from small cell carci-
noma because of the cytological features.
In 1980, pulmonary neuroendocrine tumors were categorized as
typical carcinoids, atypical carcinoids, and small cell carcinomas.8
However, some authors indicated that a fourth category may exist
between atypical carcinoids and small cell carcinoma in prog-
nosis.9,10 In 1991, Travis et al.1 proposed a new category for LCNEC
and reported that the prognosis of LCNEC fell between atypical
carcinoids and small cell carcinoma.1 In 1998, Travis et al.11 re-
ported further LCNEC cases. The histological LCNEC criteria
proposed by the WHO in 1999 are as follows2: 1) a tumor with
neuroendocrine morphological features (organoid nesting, pali-
sading, rosettes, and trabeculae); 2) a high mitotic rate of 11
mitoses per 2 mm2; 3) necrosis (often in large zones); and 4)
cytological features of non-small-cell carcinoma; i.e., large cells,
low nuclear/cytoplasmic ratio, vesicular or ﬁne chromatin, and/orFig. 1. Flexible bronchoscopy demonstrates a polypoid tumor almost obstructing the
oriﬁce of the subsegmental bronchus (B8b) of the anterior basal segment of the right
lower lobe (a). Gross examination shows a 1.0  0.9  0.8-cm white tumor originating
from the bronchial mucosa of B8b (b). The tumor is not invading the pulmonary
parenchyma (c).
Fig. 2. Histological examination shows solid growth patterns including trabeculae (a) and pseudorosettes (b). Focal necrosis is also seen (c), and at a higher magniﬁcation, the
neoplastic cells are large and polygonal and have a low nuclear-to-cytoplasmic ratio and ﬁnely granular chromatin (d).
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neuroendocrine markers such as chromogranin, synaptophysin,
and neural-cell-adhesion-molecule as assessed by immunohisto-
chemistry, or they contain neuroendocrine granules as detected by
electronmicroscopy. To date, LCNEC is classiﬁed as a variant of large
cell carcinoma in non-SCLC. LCNEC shows characteristic cytomor-
phological arrangements such as palisading or rosettes withFig. 3. Immunohistochemical examination shows positive staininnecrosis. In contrast, classic large cell carcinomas show bizarre cells
with inﬂammatory cell inﬁltration. The morphometry analysis
showed signiﬁcantly different tumor cell sizes between LCNEC and
classic large cell carcinoma.12 Our case is compatible with the
criteria of LCNEC.
In general, patients with stage I LCNEC have a signiﬁcantly
poorer prognosis than those with other stage I non-small-cell lungg for synaptophysin (a), chromogranin A (b), and CD56 (c).
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small-cell lung cancer.4 A published surgical series report on LCNEC
mentioned that the 5-year survivals for overall and stage I LCNEC
are 21.2e57% and 27e67%, respectively.13,14 Even patients with
tumors diagnosed at an early stage do not have a good prognosis.
On the other hand, the present patient had a good prognosis. We
believe that that central-type LCNEC has a better prognosis than
peripheral-type LCNEC simply because the clinical symptoms, such
as cough, bloody sputum, or pneumonia, tend to occur in the
endobronchial location.
This patient underwent complete resection with early success.
Roentgenological LCNEC has not been reported to-date, and the
prognosis is not known in detail. Although this patient achieved
a longperiodof health,webelieve that close follow-up ismandatory.Conﬂict of interest policy
The authors have no commercial associations or sources of
support that may pose a conﬂict of interest.
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